Rinat Sack is a seasoned CMC and formulation expert with 20 years of experience in leading drug companies. Currently serving as the Head of CMC at Meridian Bioscience Inc., Rinat manages strategic and operational CMC activities for both commercial products and those in development. Rinat has previously held significant roles at Chiasma, Teva Pharmaceuticals, Eloxx Pharmaceuticals, FutuRx, and Neurim Pharmaceuticals, overseeing various stages of drug development and regulatory submissions. Rinat holds a BSc in Chemical Engineering from the Technion, an MSc from the Weizmann Institute, and is currently pursuing an MBA in Healthcare Innovation from Reichman University. Fluent in English and knowledgeable in Spanish, Rinat is also an animal lover.
This person is not in any teams
This person is not in any offices